Nuclear Medicine and Biology
Volume 36, Issue 6 , Pages 671-680 , August 2009

Evaluation of an anti-p185HER2 (scFv-CH2-CH3)2 fragment following radioiodination using two different residualizing labels: SGMIB and IB-Mal-d-GEEEK

  • Ganesan Vaidyanathan

      Affiliations

    • Duke University Medical Center, Durham, NC 27710, USA
    • Corresponding Author InformationCorresponding author. Radiology, Duke University Medical Center, Box 3808, Durham, NC 27710, USA. Tel.: +1 919 684 7811; fax: +1 919 684 7122.
    • ,
  • Emmanuelle Jestin

      Affiliations

    • Duke University Medical Center, Durham, NC 27710, USA
    • ,
  • Tove Olafsen

      Affiliations

    • Department of Molecular and Medical Pharmacology, Crump Institute for Molecular Imaging, David Geffen School of Medicine at University of California Los Angeles, Los Angeles, CA 90095, USA
    • ,
  • Anna M. Wu

      Affiliations

    • Department of Molecular and Medical Pharmacology, Crump Institute for Molecular Imaging, David Geffen School of Medicine at University of California Los Angeles, Los Angeles, CA 90095, USA
    • AMW is a member of the UCLA Johnson Comprehensive Cancer Center (CA16042).
    • ,
  • Michael R. Zalutsky

      Affiliations

    • Duke University Medical Center, Durham, NC 27710, USA

Received 29 October 2008 ,Revised 31 March 2009 ,Accepted 2 April 2009.

To access this article, please choose from the options below

Login to an existing account or Register a new account.

  • Purchase this article for 31.50 USD (You must login/register to purchase this article)

    Online access for 24 hours. The PDF version can be downloaded as your permanent record.

  • Subscribe to this title

    Get unlimited online access to this article and all other articles in this title 24/7 for one year.

  • Claim access now

    For current subscribers with Society Membership or Account Number.

  • Visit SciVerse ScienceDirect to see if you have access via your institution.

☆ This work was supported by Grants CA42324, CA14236, CA43904 and CA86306 from the National Institutes of Health.

PII: S0969-8051(09)00089-4

doi: 10.1016/j.nucmedbio.2009.04.002

Nuclear Medicine and Biology
Volume 36, Issue 6 , Pages 671-680 , August 2009

Article Tools

* Image Usage & Resolution